Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2.

Title: Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2.
Authors: Odilon Nouatin; Juliana Boex Mengue; Jean Claude Dejon-Agobé; Rolf Fendel; Javier Ibáñez; Ulysse Ateba Ngoa; Jean Ronald Edoa; Bayodé Roméo Adégbité; Yabo Josiane Honkpéhédji; Jeannot Fréjus Zinsou; Aurore Bouyoukou Hounkpatin; Kabirou Moutairou; Andreas Homoet; Meral Esen; Andrea Kreidenweiss; Stephen L Hoffman; Michael Theisen; Adrian J F Luty; Bertrand Lell; Selidji Todagbe Agnandji; Ghyslain Mombo-Ngoma; Michael Ramharter; Peter Kremsner; Benjamin Mordmüller; Ayôla Akim Adegnika
Source: PLoS Neglected Tropical Diseases, Vol 15, Iss 6, p e0009361 (2021)
Publisher Information: Public Library of Science (PLoS)
Publication Year: 2021
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: Arctic medicine. Tropical medicine; RC955-962; Public aspects of medicine; RA1-1270
Description: Background Helminths can modulate the host immune response to Plasmodium falciparum and can therefore affect the risk of clinical malaria. We assessed here the effect of helminth infections on both the immunogenicity and efficacy of the GMZ2 malaria vaccine candidate, a recombinant protein consisting of conserved domains of GLURP and MSP3, two asexual blood-stage antigens of P. falciparum. Controlled human malaria infection (CHMI) was used to assess the efficacy of the vaccine. Methodology In a randomized, double-blind Phase I clinical trial, fifty, healthy, lifelong malaria-exposed adult volunteers received three doses of GMZ2 adjuvanted with either Cationic Adjuvant Formulation (CAF) 01 or Alhydrogel, or a control vaccine (Rabies) on days (D) 0, D28 and D56, followed by direct venous inoculation (DVI) of 3,200 P. falciparum sporozoites (PfSPZ Challenge) approximately 13 weeks after last vaccination to assess vaccine efficacy. Participants were followed-up on a daily basis with clinical examinations and thick blood smears to monitor P. falciparum parasitemia for 35 days. Malaria was defined as the presence of P. falciparum parasites in the blood associated with at least one symptom that can be associated to malaria over 35 days following DVI of PfSPZ Challenge. Soil-transmitted helminth (STH) infection was assessed by microscopy and by polymerase chain reaction (PCR) on stool, and Schistosoma infection was assessed by microscopy on urine. Participants were considered as infected if positive for any helminth either by PCR and/or microscopy at D0 and/or at D84 (Helm+) and were classified as mono-infection or co-infection. Total vaccine-specific IgG concentrations assessed on D84 were analysed as immunogenicity outcome. Main findings The helminth in mono-infection, particularly Schistosoma haematobium and STH were significantly associated with earlier malaria episodes following CHMI, while no association was found in case of coinfection. In further analyses, the anti-GMZ2 IgG concentration on D84 was significantly ...
Document Type: article in journal/newspaper
Language: English
Relation: https://doi.org/10.1371/journal.pntd.0009361; https://doaj.org/toc/1935-2727; https://doaj.org/toc/1935-2735; https://doaj.org/article/bb9e94c7a35042c8863884855ee8d7a3
DOI: 10.1371/journal.pntd.0009361
Availability: https://doi.org/10.1371/journal.pntd.0009361; https://doaj.org/article/bb9e94c7a35042c8863884855ee8d7a3
Accession Number: edsbas.8405C15F
Database: BASE